VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio newsletters will not be
published on April
3rd-6th; they will resume distribution on Tuesday, April
7th.
|
 |
| April
2, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- Akebia Therapeutics: Appoints
Biopharmaceutical Leader Philip Vickers, Ph.D.
to Its Board of Directors More
- Ardelyx: Rajani Dinavahi, MD, Appointed
Chief Medical Officer
More
- AvenCell Therapeutics: First Patient Dosed
in Phase I QUADvance Study With AVC-203, a
Novel Allogeneic CD19/CD20 Dual-Targeting
CAR-T Investigational Therapy for the
Treatment of Relapsed/Refractory B-Cell
Malignancies More
- Bambusa Therapeutics: Positive Results From
the Phase 1 Multiple Ascending Dose Trial of
BBT001 at the 2026 American Academy of
Dermatology (AAD) Annual Meeting
More
- Beam Therapeutics: Publication of BEACON
Phase 1/2 Data for risto-cel in Patients With
Sickle Cell Disease (SCD) in The New England
Journal of Medicine More
- CanWell
Pharma: FDA Clearance of the IND for CAN016, a
Dual-Payload ADC Targeting HER2, for ADC
Pre-Treated Solid Tumors More
- Iterative Health and US Heart &
Vascular: Enter Strategic Partnership to
Advance Community-Based Cardiovascular
Research More
- Neutrolis: Positive First-in-Human Phase 1a
Results From LIBERATE-I Trial of NTR-1011, a
First-in-Class DNASE1L3 Fusion Protein More
- PureTech: Publication of Phase 2b ELEVATE
IPF Trial Results in The American Journal of
Respiratory and Critical Care Medicine More
- Seaport Therapeutics: Positive Proof of
Concept Topline Results From Ongoing Phase 1
Trial of GlyphAgo in Healthy Volunteers More
More
- Thermo Fisher Scientific: Introduces the
Gibco CTS Compleo Fill and Finish System to
Help Streamline Cell Therapy Manufacturing More
- Thermo Fisher Scientific: Launches
Integrated Platform to Accelerate Biologics
Development More
|
|
 |
We
help you focus on the science.
Let Charles River CFO
provide the financial insight you
need.
Flexible fractional and
interim solutions. |
|
Learn More
→ |
|
|
- Boston VC Funding Hits $1 Billion in March
as One Startup Reaches ‘Decacorn’ Status More*
- Mass. Companies Close Major Deals in
Biotech, Media in March More*
- More on Cyclerion Providing Public
Listing Vehicle for Korsana in $380M Deal More*
More*
More*
More
- Vor Bio: Inducement Grant Under Nasdaq
Listing Rule 5635(c)(4) More
|
|
|
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- Empowering Students Through STEM: A
Conversation With Massachusetts Science &
Engineering Fair Executive Director Helen
Rosenfeld More
- From Seed to Series C: What
Investors Look for Beyond the Science More
- ICYMI: CEO’s Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO’s Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- More Than Executive Search: Building
Leadership for Every Stage of Growth More
- Recursion Appoints Former Exelixis CMO; More
Executive Moves at Incyte More*
- The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
